More Impedimed Limited news
Impedimed LimitedASX: IPD

ImpediMed Achieves Critical Mass in First Key Target State

Jun 28, 2023 at 11:53 PM EDT · Issued by Impedimed Limited

Filed with ASX · Jun 28, 2023 at 11:53 PM EDT

On 6ix: 6ix.com/news/impedimed-achieves-critical-mass-in-first-key-target-state

Watch Impedimed's latest call↗Impedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call↗

Impedimed Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Impedimed Limited on 6ix

Earlier from Impedimed

  • SPP ResultsJun 21, 2023
  • ImpediMed Announces Third Medical Policy Covering SOZOJun 20, 2023
  • First Published Medical Policy from Blue Cross Blue ShieldJun 4, 2023
  • Share Purchase Plan OpensMay 30, 2023
  • First Published Medical Policy for Bioimedance SpectroscopyMay 24, 2023

Later from Impedimed

  • First Top 5 National Payor Covering SOZO TestingJul 19, 2023
  • APPENDIX 4C - Quarterly Activities ReportJul 23, 2023
  • Appendix 4C & Quarterly Activities Report - Sep-23 QtrOct 30, 2023
  • Largest US Private Payor Updates Medical Policy for BISNov 2, 2023
  • ImpediMed announces leadership and Board changesNov 19, 2023
All Impedimed news releases↗

Follow Impedimed into a list and get an email when it puts out news.

Follow Impedimed
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer